Emcure Pharmaceuticals Ltd., a leading Indian pharma company with a strong focus on women’s health, announces its entry into the daily supplements space with the expansion of its Arth range. With a ...

Motilal Oswal, has come out with its report on Emcure Pharmaceuticalss Ltd. The research firm has recommended to “ Subscribe- Long Term” the ipo in its research report as on July 02 2024.

Emcure Pharmaceuticals Ltd. has announced its entry into the daily supplements segment with an expansion of its Arth range, further strengthening its focus on women’s health. The pharmaceutical ...

Emcure Pharmaceuticals has opened its new formulation research and development (R&D) centre in Ahmedabad, in the Indian state of Gujarat. The centre will focus on developing complex drug delivery ...

Emcure Pharmaceuticals, an Indian pharma company focused on women’s health, has entered the daily supplements market with an expansion of its Arth range. Arth offers supplements that combine ...